Recently, FOXC1 has been shown to activate GLI2 in a SMO independent SHH pathway (Figure 3), which partly explains the aggressiveness of BLBC cell and adds a new role for FOXC1 in cancer cell stemness [7]. This evidence concerns the gene GLI2 and cancer.